Low ball offer, Gilead Capital is unlikely to accept as their purchase cost is about $1.15 per share.
- Forums
- ASX - By Stock
- ISD
- Ann: Isentia 2018 Annual Report
Ann: Isentia 2018 Annual Report, page-39
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ISD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online